<unk>  is indicated for the treatment of cutaneous manifestations of cutaneous T-cell lymphoma in people who are refractory to at least one prior systemic therapy (oral) and for the topical treatment of cutaneous lesions in patients with CTCL who have refractory or persistent disease after other therapies or who have not tolerated other therapies (topical). It has been used off-label for non-small cell lung cancer and breast cancer.
Bexarotene
Trifarotene
Tazarotene
Sulfalene
Retinol
Metenolone enanthate
Trenbolone enanthate
Stenbolone acetate